insys
Former Insys sales exec sentenced to a year in prison for offering lap dances to encourage fentanyl spray prescriptions
January 23, 2020Medical Communications, Sales and Marketing insys, pharma
A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to …
Insys Therapeutics files for bankruptcy
June 11, 2019Manufacturing and Production DoJ, Subsys, bankruptcy, insys, pharma
Opioid drugmaker Insys Therapeutics has filed for Chapter 11 bankruptcy protection after agreeing to pay $225 million to settle charges …
Top Ten most popular articles on Pharmafile.com this week!
February 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10
Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …
Stripper-turned-Insys sales rep gave lap dance to persuade doctor to prescribe fentanyl
January 31, 2019Medical Communications Sunrise Lee, US, chicago, corruption, insys, sales
A pharmaceutical executive working for Insys therapeutics has been accused of giving a doctor a lap dance in an effort …
Insys Therapeutics reaches $150m agreement to settle opioid marketing case
August 9, 2018Medical Communications, Sales and Marketing Litigation, Subsys, US Department of Justice, fentanyl, insys, opioid, pharma
The Arizona-based pharma company Insys Therapeutics has reached an agreement to pay $150 million to the US Department of Justice …
FDA rejects Insys Therapeutics sublingual opioid spray
July 31, 2018Manufacturing and Production Crisis, FDA, insys, opioid, rejection, spray
The FDA has rejected Insys Therapeutics buprenorphine sublingual spray due to concerns about the safety of the Arizona-based company’s opioid …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
